Milestone Scientific Inc. (MLSS)
NYSEAMERICAN: MLSS · Real-Time Price · USD
0.7270
-0.0330 (-4.34%)
Jun 27, 2025, 4:00 PM - Market closed
Milestone Scientific Revenue
Milestone Scientific had revenue of $2.23M in the quarter ending March 31, 2025, a decrease of -0.73%. This brings the company's revenue in the last twelve months to $8.61M, down -9.13% year-over-year. In the year 2024, Milestone Scientific had annual revenue of $8.63M, down -12.19%.
Revenue (ttm)
$8.61M
Revenue Growth
-9.13%
P/S Ratio
8.20
Revenue / Employee
$506,677
Employees
17
Market Cap
57.05M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.63M | -1.20M | -12.19% |
| Dec 31, 2023 | 9.83M | 1.02M | 11.60% |
| Dec 31, 2022 | 8.81M | -1.50M | -14.54% |
| Dec 31, 2021 | 10.30M | 4.87M | 89.52% |
| Dec 31, 2020 | 5.44M | -2.94M | -35.07% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.98B |
| Novartis AG | 53.22B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
MLSS News
- 5 weeks ago - Milestone Scientific Appoints Highly Accomplished MedTech Executive Shanth Thiyagalingam to Board of Directors - GlobeNewsWire
- 6 weeks ago - Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2025 - GlobeNewsWire
- 3 months ago - Milestone Scientific Expands CompuFlo® Epidural System Footprint with InfiniSurg, LLC in New Jersey - GlobeNewsWire
- 5 months ago - Milestone Scientific Expands Adoption of CompuFlo® Epidural System with Commercial Rollout at Pain Doctors Medical LLC - GlobeNewsWire
- 5 months ago - Milestone Scientific Announces Commercial Rollout of CompuFlo® Epidural System at Advanced Spine and Pain Management Following Successful Pilot with Dr. Varinder Dhillon - GlobeNewsWire
- 7 months ago - Milestone Scientific to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference on December 11th, 2024 - GlobeNewsWire
- 7 months ago - Milestone Scientific Secures Federal Supply Schedule (FSS) Approval on Contract for CompuFlo® Epidural System - GlobeNewsWire
- 8 months ago - Milestone Scientific Inc. (MLSS) Q3 2024 Earnings Call Transcript - Seeking Alpha